☰

Suja S. Rajan, Ph.D. - Publications

Affiliations: 
2009 Health Policy And Management University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Health Care Management, General Economics, Pharmacy
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Bhansali A, Sansgiry S, Essien E, Fleming M, Rajan S, Mehta P. Effect of Patient Involvement and Message Format on Perceived Susceptibility and Severity to Breast Cancer Value in Health. 21. DOI: 10.1016/J.Jval.2018.04.825  0.32
2016 Rajan SS, Suryavanshi MS, Karanth S, Lairson DR. The Immediate Impact of the 2009 USPSTF Screening Guideline Change on Physician Recommendation of a Screening Mammogram: Findings from a National Ambulatory and Medical Care Survey-Based Study. Population Health Management. PMID 27564582 DOI: 10.1089/Pop.2015.0180  0.305
2016 Taylor JS, Zhang N, Meyer L, Ramondetta LM, Bodurka DC, Rajan S, Giordano SH. When more is less: End-of-life disparities among ovarian cancer patients. Journal of Clinical Oncology. 34: e21517-e21517. DOI: 10.1200/Jco.2016.34.15_Suppl.E21517  0.312
2015 Highfield L, Rajan SS, Valerio MA, Walton G, Fernandez ME, Bartholomew LK. A non-randomized controlled stepped wedge trial to evaluate the effectiveness of a multi-level mammography intervention in improving appointment adherence in underserved women. Implementation Science : Is. 10: 143. PMID 26464110 DOI: 10.1186/S13012-015-0334-X  0.313
2015 Rajan SS, Begley CE, Highfield LD, Kim B. Survival Benefits of Treatment Access Among Underserved Breast Cancer Patients Diagnosed Through the Texas Breast and Cervical Cancer Services Program. Journal of Public Health Management and Practice : Jphmp. PMID 25794245 DOI: 10.1097/Phh.0000000000000255  0.317
2015 Jadav S, Rajan SS, Abughosh S, Sansgiry SS. The Role of Socioeconomic Status and Health Care Access in Breast Cancer Screening Compliance Among Hispanics. Journal of Public Health Management and Practice : Jphmp. 21: 467-76. PMID 25756197 DOI: 10.1097/Phh.0000000000000235  0.324
2015 Kadakia A, Rajan SS, Abughosh S, Du XL, Johnson ML. CMF-regimen preferred as first-course chemotherapy for older and sicker women with breast cancer: Findings from a SEER-Medicare-based population study. American Journal of Clinical Oncology. 38: 165-73. PMID 23608830 DOI: 10.1097/Coc.0B013E31828F5B01  0.342
2014 Rajan SS, Cai Y, Yi M, Tsai CL, Du XL. Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients Receiving Chemotherapy: A SEER-Medicare-based Study. American Journal of Clinical Oncology. PMID 25068470 DOI: 10.1097/Coc.0000000000000104  0.301
2014 Rajan SS, Begley CE, Kim B. Breast cancer stage at diagnosis among medically underserved women screened through the Texas Breast and Cervical Cancer Services. Population Health Management. 17: 202-10. PMID 24921895 DOI: 10.1089/Pop.2013.0079  0.32
2013 Rajan SS, Carpenter WR, Stearns SC, Lyman GH. Short-term costs associated with primary prophylactic G-CSF use during chemotherapy. The American Journal of Managed Care. 19: 150-9. PMID 23448112  0.477
2012 Yang M, Rajan S, Issa AM. Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model. Cancer. 118: 5163-70. PMID 22359236 DOI: 10.1002/Cncr.27443  0.334
2012 Kadakia A, Rajan S, Du X, Johnson M. PCN125 Predictors of Methotrexate Containing Chemotherapy in Women Diagnosed With Early Stage Breast Cancer Value in Health. 15: A230. DOI: 10.1016/J.Jval.2012.03.1242  0.31
2011 Rajan SS, Stearns SC, Lyman GH, Carpenter WR. Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients. Breast Cancer Research and Treatment. 130: 255-66. PMID 21584667 DOI: 10.1007/S10549-011-1553-8  0.524
2011 Rajan SS, Lyman GH, Stearns SC, Carpenter WR. Effect of primary prophylactic granulocyte-colony stimulating factor use on incidence of neutropenia hospitalizations for elderly early-stage breast cancer patients receiving chemotherapy. Medical Care. 49: 649-57. PMID 21478779 DOI: 10.1097/Mlr.0B013E318215C42E  0.543
2011 Rajan SS, Lyman GH, Carpenter WR, Stearns SC. Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer. Breast Cancer Research and Treatment. 127: 511-20. PMID 20976544 DOI: 10.1007/S10549-010-1216-1  0.547
2011 Rajan S, Lyman G. PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad? Value in Health. 14: A444. DOI: 10.1016/J.Jval.2011.08.1160  0.342
Show low-probability matches.